Published in Neuropsychiatr Dis Treat on July 30, 2015
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc (2012) 13.94
National trends in the outpatient treatment of depression. JAMA (2002) 7.09
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA (1999) 6.05
Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ (2014) 5.84
Development of a rational scale to assess the harm of drugs of potential misuse. Lancet (2007) 5.42
Benzodiazepine use in the United States. JAMA Psychiatry (2015) 5.39
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull (2009) 4.69
Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med (2008) 4.48
Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend (2006) 4.24
Time-related predictors of suicide in major affective disorder. Am J Psychiatry (1990) 3.93
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry (2014) 3.27
Benzodiazepines revisited--will we ever learn? Addiction (2011) 3.18
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ (1998) 2.61
Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry (2004) 2.54
Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2009) 2.48
Anxiety and depression in later life: Co-occurrence and communality of risk factors. Am J Psychiatry (2000) 2.28
Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. BMJ (2001) 2.22
The night-eating syndrome; a pattern of food intake among certain obese patients. Am J Med (1955) 2.22
Neural bases for addictive properties of benzodiazepines. Nature (2010) 2.17
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord (2009) 2.17
Benzodiazepine use and aggressive behaviour: a systematic review. Aust N Z J Psychiatry (2014) 2.04
Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol (2008) 2.04
Co-morbidity of eating disorders and substance abuse review of the literature. Int J Eat Disord (1994) 2.01
A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging (2012) 1.97
Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry (2004) 1.90
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders. Aust N Z J Psychiatry (2014) 1.89
Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry (2001) 1.87
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev (2014) 1.86
Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs (2004) 1.86
Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry (2012) 1.84
Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry (2009) 1.81
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol (2010) 1.74
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom (2013) 1.73
Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract (2011) 1.71
Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy (2004) 1.71
Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study. J Clin Psychiatry (2009) 1.71
Treatment of patients with eating disorders,third edition. American Psychiatric Association. Am J Psychiatry (2006) 1.70
Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry (2004) 1.70
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med (2004) 1.64
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry (2000) 1.56
Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res (2012) 1.56
Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry (1998) 1.54
Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry (2004) 1.51
Is Lorazepam a treatment for neuroleptic malignant syndrome? CNS Spectr (2000) 1.50
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med (2014) 1.49
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract (2012) 1.49
Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol (2002) 1.46
Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol (1990) 1.45
Psychopharmacology in supportive care in cancer: a review for the clinician. I. Benzodiazepines. Support Care Cancer (1999) 1.40
Use and abuse of flunitrazepam. Ann Pharmacother (1998) 1.39
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry (2014) 1.39
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol (2014) 1.36
Benzodiazepines, posttraumatic stress disorder, and veterans: good news and why we're not done yet. J Clin Psychiatry (2012) 1.31
Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol (2004) 1.31
Training and practice of psychotherapy in Europe: results of a survey. World Psychiatry (2011) 1.28
Follow-up and family study of anxious depression. Am J Psychiatry (1991) 1.26
Epidemiologic and clinical updates on impulse control disorders: a critical review. Eur Arch Psychiatry Clin Neurosci (2006) 1.25
Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry (2012) 1.24
Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatr Serv (2003) 1.23
Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol (1997) 1.21
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry (2006) 1.16
New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord (2010) 1.15
Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence. Drug Alcohol Depend (2008) 1.15
Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend (1991) 1.14
Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv (2002) 1.13
Anxiety in the eating disorders: understanding the overlap. Clin Psychol Rev (2007) 1.13
The eating disorders as addiction: a psychobiological perspective. Addict Behav (1998) 1.13
Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry (1996) 1.12
Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Hum Psychopharmacol (2013) 1.12
Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry (2004) 1.12
Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol (2014) 1.11
Psychosocial and clinical predictors of unipolar depression outcome in older adults. Int J Geriatr Psychiatry (2002) 1.10
The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives. Scand J Prim Health Care (2007) 1.10
Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med (2005) 1.10
Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord (1998) 1.09
Drug-induced urinary retention: incidence, management and prevention. Drug Saf (2008) 1.09
Usage of benzodiazepines: A review. Int J Psychiatry Clin Pract (2010) 1.07
Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs (2013) 1.07
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry (2010) 1.07
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol (2007) 1.06
Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep (2003) 1.06
Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database. J Affect Disord (2002) 1.05
Challenges for trainees in psychiatry and early career psychiatrists. Int Rev Psychiatry (2013) 1.04
Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry (1988) 1.04
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry (2011) 1.03
Novel psychoactive substances in young adults with and without psychiatric comorbidities. Biomed Res Int (2014) 1.02
Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J Affect Disord (2008) 1.02
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. J Clin Psychiatry (2008) 1.01
Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol (2012) 0.99
Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death. Hum Psychopharmacol (2012) 0.99
Benzodiazepines - Their role in aggression and why GPs should prescribe with caution. Aust Fam Physician (2011) 0.99
Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa? Biol Psychiatry (2013) 0.98
Much more medicine for the oldest old: trends in UK electronic clinical records. Age Ageing (2014) 0.98
Aggressive dyscontrol in patients treated with benzodiazepines. J Clin Psychiatry (1988) 0.98
Mental health research priorities for Europe. Lancet Psychiatry (2015) 1.49
Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom (2014) 1.46
WPA contribution to the development of the chapter on mental disorders of the ICD-11: An update. World Psychiatry (2013) 0.98
Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort. Biol Psychiatry (2015) 0.94
Priorities for mental health research in Europe: A survey among national stakeholders' associations within the ROAMER project. World Psychiatry (2013) 0.91
Improving education, policy and research in mental health worldwide: the role of the WPA Collaborating Centres. World Psychiatry (2016) 0.90
Training in psychiatry throughout Europe. Eur Arch Psychiatry Clin Neurosci (2016) 0.88
The new impact factor and immediacy index of World Psychiatry. World Psychiatry (2012) 0.87
Following the development of ICD-11 through World Psychiatry (and other sources). World Psychiatry (2014) 0.85
Arsenic: Association of regional concentrations in drinking water with suicide and natural causes of death in Italy. Psychiatry Res (2017) 0.85
This is why there is hope for psychiatry. World Psychiatry (2014) 0.82
Use of coercive measures in mental health practice and its impact on outcome: a critical review. Expert Rev Neurother (2014) 0.81
Pathways to mental health care in Italy: results from a multicenter study. Int J Soc Psychiatry (2013) 0.80
Cerebral connectivity and psychotic personality traits. A diffusion tensor imaging study. Eur Arch Psychiatry Clin Neurosci (2008) 0.79
The role of relatives in pathways to care of patients with a first episode of psychosis. Int J Soc Psychiatry (2015) 0.78
What is the current status of training and practice of early intervention in psychiatry? Results from a survey in 35 countries. Early Interv Psychiatry (2013) 0.78
Investigation of Oxytocin Secretion in Anorexia Nervosa and Bulimia Nervosa: Relationships to Temperament Personality Dimensions. Eur Eat Disord Rev (2015) 0.78
Development and validation of the Family Coping Questionnaire for Eating Disorders. Int J Eat Disord (2014) 0.77
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives. Schizophr Res (2016) 0.77
The Family Assessment Device: A Clinimetric Analysis. Psychother Psychosom (2016) 0.76
Cardiovascular risk factors among people with severe mental illness in Italy: a cross-sectional comparative study. Gen Hosp Psychiatry (2014) 0.76
The adolescent emotional coping after an earthquake: a risk factor for suicidal ideation. J Adolesc (2014) 0.76
Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study. J Psychiatr Res (2017) 0.76
Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis. J Psychiatr Res (2017) 0.75
Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy. Int J Ment Health Syst (2015) 0.75
Recovery and decision-making involvement in people with severe mental illness from six countries: a prospective observational study. BMC Psychiatry (2017) 0.75
Add-on oral olanzapine worsens hallucinations in schizoaffective disorder. BMJ Case Rep (2014) 0.75
Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders. Curr Neuropharmacol (2017) 0.75
Including family members in psychoeducation for bipolar disorder: is it worth it? Bipolar Disord (2015) 0.75
The new impact factor of World Psychiatry. World Psychiatry (2013) 0.75
A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts. Neuropsychiatr Dis Treat (2016) 0.75
Suicide Prevention in Schizophrenia: Do Long-Acting Injectable Antipsychotics (LAIs) have a role? CNS Neurol Disord Drug Targets (2017) 0.75
Well-Being Therapy in a Patient with Panic Disorder Who Failed to Respond to Paroxetine and Cognitive Behavior Therapy. Psychother Psychosom (2015) 0.75
Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disaster. Psychiatry Res (2016) 0.75
[Prima Guerra Mondiale e salute mentale: uno studio retrospettivo su veterani ricoverati in un ospedale psichiatrico tra il 1915 e il 1918]. Riv Psichiatr (2017) 0.75
Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry (2017) 0.75
Gender and occupational role differences in work-related post-traumatic stress symptoms, burnout and global functioning in emergency healthcare workers. Intensive Crit Care Nurs (2021) 0.75
Leucocytosis in clozapine-treated patients as predictor of loss of treatment response? BMJ Case Rep (2015) 0.75
The Relationship between Childhood Maltreatment and Non-Suicidal Self-Injury: A Systematic Review. Front Psychiatry (2017) 0.75
The Role of Staging in Planning Psychotherapeutic Interventions in Depression. J Clin Psychiatry (2017) 0.75
Erratum to: Responses of peripheral endocannabinoids and endocannabinoid‑related compounds to hedonic eating in obesity. Eur J Nutr (2016) 0.75
Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study. Depress Anxiety (2013) 0.75
Development of an international schedule for the assessment and staging of care for dementia. J Alzheimers Dis (2015) 0.75
Three-Month Follow-up Study of Mental Health Outcomes After a National COVID-19 Lockdown: Comparing Patients With Mood or Anxiety Disorders Living in an Area With a Higher Versus Lower Infection Incidence. J Clin Psychiatry (2022) 0.75
Is Menstrual Dysphonia Associated With Greater Disability and Lower Quality of Life? J Voice (2015) 0.75
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy. BMC Psychiatry (2017) 0.75
How do relatives cope with eating disorders? Results from an Italian multicentre study. Int J Eat Disord (2016) 0.75
Well-being therapy in depression: New insights into the role of psychological well-being in the clinical process. Depress Anxiety (2017) 0.75
Differential associations of affective temperaments and diagnosis of major affective disorders with suicidal behavior. J Affect Disord (2016) 0.75
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: an exploratory study. Compr Psychiatry (2014) 0.75
A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects. J Clin Psychiatry (2017) 0.75